Direct oral anticoagulants increase bleeding risk after intracerebral hemorrhage in patients with atrial fibrillation
1. Ischemic stroke occurred less often in patients with atrial fibrillation on DOACs compared to those on placebo. 2. Patients ...
Tag: DOAC
#VisualAbstract Early Oral Anticoagulation is Non-inferior to Delayed Treatment in Patients with Ischemic Stroke and Atrial Fibrillation
1. Early DOAC therapy within 4 days was non-inferior to delayed therapy for the composite outcome of recurrent ischemic or ...
#VisualAbstract: Early Timing of Anticoagulation after Acute Ischemic Stroke with Atrial Fibrillation was Noninferior to Delayed Timing
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Patterns of oral anticoagulation use and adherence for atrial fibrillation from 2010-2020
1. This cohort study of older adults under the Medicare Advantage insurance plan demonstrated that from 2010 to 2020, there ...
Left atrial appendage occlusion is an effective alternative to oral anticoagulation in atrial fibrillation
1. The overall benefit of left atrial appendage occlusion (LAOO) for prevention of stroke in patients with atrial fibrillation (AF) ...
Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation
1. Asundexian 50 mg resulted in a lower rate of bleeding compared to apixaban 5 mg twice daily. 2. The ...
Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
Rivaroxaban superior to aspirin at reducing recurrent stroke in patients with embolic stroke of undetermined source and left ventricular dysfunction: (NAVIGATE ESUS Trial)
1. Rivaroxaban was superior to aspirin in reducing recurrent stroke or systemic embolism among patients with recent embolic stroke of ...
#VisualAbstract: Aspirin treatment without indication in patients on direct oral anticoagulants may increase the risk of bleeding events
1. In patients treated with direct oral anticoagulants (DOACs) for atrial fibrillation or venous thromboembolism (VTE), adding aspirin (ASA) was ...